2012Unpublished venueRequires access

Effects of L-carnitine on Blood Lipid Metabolism and Antioxidation in Hyperlipidemia Rats

Guihua Wang

Open publisher page 0 citations

Abstract

[Objective] To study the effects of L-carnitine (LC) on lowering the high blood lipid and antioxidation in hyperlipidemia rats. [Method] 50 healthy SD rats were randomly divided into 5 groups. They were fed with standard diet, high-cholesterol diet and high-cholesterol diet with 0.25, 0.5, 1.0 g/(kg·d) LC. After the LC groups were consecutively orally administered LC for 28 days, rat serum total cholesterol (TC), triglyceride (TG), high density lipoprotein (HDL-C), low density lipoprotein (LDL-C) content, as well as super oxide dismutase (SOD) activity and malondialdehyde (MDA) content in serum and liver were determined. [Result] Compared with the high-fat model group, LC could significantly reduce the serum TC, TG, LDL-C levels, increase HDL-C level, and enhance SOD activity in serum and liver, decrease the content of MDA (P0.05). [Conclusion] LC might have a significant role in lowering the high blood lipid and improving internal antioxidant capacity in hyperlipidemia rats.

About this research paper

What this paper is about

[Objective] To study the effects of L-carnitine (LC) on lowering the high blood lipid and antioxidation in hyperlipidemia rats. [Method] 50 healthy SD rats were randomly divided into 5 groups. They were fed with standard diet, high-cholesterol diet and high-cholesterol diet with 0.25, 0.5, 1.0 g/(kg·d) LC. After the LC groups were consecutively orally administered LC for 28 days, rat serum total cholesterol (TC), triglyceride (TG), high density lipoprotein (HDL-C), low density lipoprotein (LDL-C) content, as well as super oxide dismutase (SOD) activity and malondialdehyde (MDA) content in serum and liver were determined. [Result] Compared with the high-fat model group, LC could significantly reduce the serum TC, TG, LDL-C levels, increase HDL-C level, and enhance SOD activity in serum and liver, decrease the content of MDA (P0.05). [Conclusion] LC might have a significant role in lowering the high blood lipid and improving internal antioxidant capacity in hyperlipidemia rats.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

[Objective] To study the effects of L-carnitine (LC) on lowering the high blood lipid and antioxidation in hyperlipidemia rats. [Method] 50 healthy SD rats were randomly divided into 5 groups. They were fed with standard diet, high-cholesterol diet and high-cholesterol diet with 0.25, 0.5, 1.0 g/(kg·d) LC. After the LC groups were consecutively orally administered LC for 28 days, rat serum total cholesterol (TC), triglyceride (TG), high density lipoprotein (HDL-C), low density lipoprotein (LDL-C) content, as well as super oxide dismutase (SOD) activity and malondialdehyde (MDA) content in serum and liver were determined. [Result] Compared with the high-fat model group, LC could significantly reduce the serum TC, TG, LDL-C levels, increase HDL-C level, and enhance SOD activity in serum and liver, decrease the content of MDA (P0.05). [Conclusion] LC might have a significant role in lowering the high blood lipid and improving internal antioxidant capacity in hyperlipidemia rats.

Key concepts: Hyperlipidemia, Malondialdehyde, Triglyceride, Carnitine, Chemistry, Endocrinology, Internal medicine, High-density lipoprotein

Related papers

Back to paper searchBrowse research topicsOriginal source
Effects of L-carnitine on Blood Lipid Metabolism and Antioxidation in Hyperlipidemia Rats — Research Paper | ScholarLens